So et al. demonstrated that CDK5 or CCNI loss sensitized cells to mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) inhibition, while p35 knockdown did not, indicating that CDK5 likely partners with CCNI in AML [109]. Here, CDK5R1 is linked to acute myeloid leukemia.